Ads
related to: bristol-myers squibb stock value- Trade
Buy, sell, track the market.
Discover our investment products.
- Ranked #1 in Research
Kiplinger's Best Online Brokers
Annual Review from August 31, 2023
- Open an Account
Choose The Account That Works
Best For You, and Start Investing
- Learn How To Trade
We can help you invest with speed
& accuracy at every step of a trade
- Trade
lp.stockstotrade.com has been visited by 10K+ users in the past month
Search results
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks· 5 days agoFree Report) has been one of the most searched-for stocks on Zacks.com lately. Over the past month, shares of this biopharmaceutical company have returned -9%, compared to the Zacks S&P 500 ...
California State Teachers Retirement System Purchases 60,431 Shares of Bristol-Myers Squibb...
ETF DAILY NEWS· 21 hours agoCalifornia State Teachers Retirement System grew its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.8% during the fourth quarter, according ...
Bristol-Myers Squibb Co. [BMY] Investment Appeal on the Rise – Knox Daily
Knox Daily· 6 days ago[NYSE:BMY] saw its stock fall -1.82% to $40.49. Over the last five days, the stock has lost -6.62%. Bristol-Myers Squibb< ...
The 5 Stocks Defining 'The Year Of The Dividend' In 2024
Benzinga via Yahoo Finance· 14 hours agoReinvested stock dividends have significantly influenced the total return of the S&P 500 since 1927....
2024 is being called ‘the year of the dividend.’ These 5 stocks keep on giving.
MarketWatch via Yahoo Finance· 3 days agoA good example is Bristol-Myers Squibb BMY. Buckingham, a value investor, says the stock is...
Health Care Roundup: Market Talk
The Wall Street Journal· 5 days agoCIMB raises Supermax’s target price to MYR0.96 from MYR0.85 while maintaining a hold rating on the stock. Shares are 1.6% lower at MYR0.91....
7 Underappreciated Stocks With 25% Return Potential in 2024
InvestorPlace· 5 days agoWhether investors refer to them as undervalued or hidden gems, underappreciated stocks are always...
This Pharma Stock Is Poised to Keep Outperforming the S&P 500
The Motley Fool via AOL· 5 days agoAstraZeneca has quietly delivered market-beating results since 2014. Despite skepticism, the company...
Market Today: Prothena's Licensing Deal with Bristol Myers and E
Guru Focus· 6 days agoMarket Overview The stock market exhibited mixed action today. There wasn't a lot of conviction from...
Cancer biotech lays off more employees in 2024, begins hunt for 'strategic options' - Boston...
The Business Journals· 6 days agoFor the second time this year, Ikena Oncology is once again cutting its workforce and slimming down...
Ads
related to: bristol-myers squibb stock valuelp.stockstotrade.com has been visited by 10K+ users in the past month
